# Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants

> **NCT05696483** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Oligomerix, Inc** · enrollment: 88 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** OLX-07010 Active
- **DRUG:** OLX-07010 Placebo

## Key facts

- **NCT ID:** NCT05696483
- **Lead sponsor:** Oligomerix, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-01-20
- **Primary completion:** 2026-01-02
- **Final completion:** 2026-02-01
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05696483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05696483, "Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05696483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*